WNT/β-catenin inhibitor ICG-001 plus radiotherapy (RT) can promote CD8+ T-cell infiltration and IFN-γ production in TILs and simultaneously reduce the number of Tregs, thus contributing to HCC treatment (101, 102). This evidence concerns the gene CD8A and hepatocellular carcinoma.